Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 47OTHER 35NIH 2NETWORK 2FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Newly Diagnosed Oligometastatic Prostate Cancer 1

Interventions

Palliative Care 2Methods 2Decision Support Techniques 2Cholecalciferol 2Calcitriol 2sulforaphane 1leucoselect phytosome 1apalutamide 1abiraterone 1Yoga 1Water 1Thioctic Acid 1Surgical Instruments 1Standard of Care 1Simvastatin 1Selective Serotonin Reuptake Inhibitors 1Radiosurgery 1Prednisone 1Perioperative Care 1Methylphenidate 1Leuprolide 1Indigo Carmine 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Herpes Zoster Vaccine 1Golytely 1Gelatin 1Fluorouracil 1Exercise Test 1Enalapril 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Has results × Abiraterone Acetate × Clear all
NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

VA Office of Research and Development

Phase 2 Completed
28 enrolled 10 charts
Genitourinary

Newly Diagnosed Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡